Gradient
- Denervation Technologies -
Gradient
Denervation Technologies
A device based solution to treat heart failure with associated pulmonary hypertension
Our
Vision
The therapeutic approach developed by Gradient Denervation Technologies aims improving cardiovascular health.
Management team
CEO - Martin Grasse
CBO - Charlotte Cavé
CMO - Dr. Lukas Guenther
CTO - David Amaoua
VP Clinical - Julie Messer
CLINICIAN FOUNDER - Dr. S. Gnanashanmugam
Board of Directors
Director - Dr. Lukas Guenther
Director - Lisa Wipperman Heine
CEO/Director - Martin Grasse
Director - Juan Pablo Mas
Director - Mano Iyer
Observer - Dr. Swami Gnanashanmugam
Our grants
EIT Health Catapult
2020 winner - Medtech 3rd place
i-Lab 2020
2020 Laureat
Want to know more about
Gradient
?
Send us your message
